International Clinical Trial: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Sonrotoclax in Participants With Severe Hepatic Impairment

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855991) titled 'A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Sonrotoclax in Participants With Severe Hepatic Impairment' on Sept. 29.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: BeOne Medicines

Condition: Hepatic Impairment Healthy Adult Participants

Intervention: Drug: Sonrotoclax

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 15, 2026

Target Sample Size: 12

To know more, visit https://clinicaltrials.gov/study/NCT07855991...